Onglyza & Kombigluze
Onglyza and Kombigluze are drugs used to treat type II diabetes. The drugs have been linked to an increased risk of heart failure. Studies have shown an increased rate of emergency room visits and hospitalizations related to heart failure, congestive heart failure, cardiac failure and death while on Onglyza and Kombigluze. The FDA Endocrinologic and Metabolic Drug Advisory Committee found an increased risk of heart failure, especially in patients with higher cardiovascular risk or impaired renal function.
Invokana also used to treat type II diabetes, has been associated with these various medical complications as drug side effects:
- Foot or Toe(s) Amputations
- Leg Amputations
- Acute Kidney Injury (AKI)
- Kidney Failure / Renal Failure
- Kidney Damage
- Diabetic Ketoacidosis (DKA)
- Ketoacidosis Complications
- Cerebral Edema
- Bowel Necrosis
If you or a loved one experienced complications or injuries related to Onglyza, Kombigluze, Invokana, or another Type II diabetes medication you may be entitled to compensation. Our team of Attorneys can help. Contact Catania & Catania, P.A. for a free case evaluation now.
We are currently investigating possible drug injury lawsuits against the responsible pharmaceutical companies for diabetes patients who have developed any of the medical conditions listed above.